Hormone therapy replaces the estrogen and progesterone your body stops making through perimenopause and menopause. It remains the most effective treatment for hot flushes, night sweats, disrupted sleep and vaginal symptoms. In November 2025 the FDA removed the boxed warnings that had frightened two generations of women away from it — and most advice online still has not caught up.
The thing that changed
What Did the FDA Actually Change in 2025?
If you were told hormone therapy causes breast cancer and heart disease, this section is for you.
Where the fear came from
In 2002 a large study called the Women's Health Initiative was halted early, and the coverage that followed was blunt: hormone therapy causes breast cancer, heart disease and dementia. Prescribing collapsed almost overnight. A generation of women went through menopause untreated, and a generation of clinicians were trained to say no.
What got lost was the detail. The average participant was 63 years old and more than a decade past menopause, on one specific oral formulation. That is not the woman of 49 with night sweats who was subsequently refused treatment on the strength of it.
What happened in November 2025
After a scientific literature review, an expert panel and a public comment period, the FDA removed the boxed warnings about cardiovascular disease, breast cancer and probable dementia from systemic menopause hormone therapy products.
The agency also pointed toward starting therapy within ten years of menopause or before age 60 for systemic treatment, which is where the evidence is strongest.
To be precise, because precision matters here: a boxed warning about endometrial cancer remains on estrogen-alone products. That is exactly why women with a uterus are prescribed progesterone alongside estrogen — it is the protection against that specific risk, and it is standard practice.
What this does not mean. It does not mean hormone therapy is right for everyone, and it does not remove the need for a proper assessment of your history. It means the conversation starts from evidence rather than from a headline.
What it treats
Symptoms Worth Treating
Perimenopause can start in your late thirties. Many women are told they are too young, or simply stressed.
- Hot FlushesAnd night sweats that ruin sleep before anything else does
- SleepWaking at three and not getting back
- Mood & AnxietyIrritability and anxiety that feel unlike you
- Brain FogWord-finding trouble and concentration that has gone
- Vaginal & UrinaryDryness, discomfort and recurrent urinary infections
- Joints & LibidoAching joints and a drop in desire, both commonly dismissed
Recurrent UTIs deserve special mention. Vaginal estrogen is well established for this, acts locally, and is frequently overlooked in women who have been handed antibiotics for years instead.
The options
Patch, Gel, Tablet or Vaginal?
Route matters more than most women are told, particularly for clot risk.
| Patch or gel | Oral tablet | Vaginal estrogen | |
|---|---|---|---|
| Absorbed via | Skin, straight into the bloodstream | Gut, then the liver first | Locally, minimal systemic absorption |
| Treats | Whole-body symptoms | Whole-body symptoms | Vaginal and urinary symptoms only |
| Clot risk | Lower, as the liver is bypassed | Higher than transdermal | Not a systemic dose |
| Suits | Most women, and the usual starting point | Those who prefer a tablet | Local symptoms, or alongside systemic therapy |
| Progesterone needed | Yes, if you have a uterus | Yes, if you have a uterus | Generally not |
A word on "bioidentical"
The term gets used two ways and the difference is worth knowing. Many FDA-approved products are body-identical — estradiol patches and micronised progesterone among them. Those are regulated, tested and consistent from box to box.
Custom-compounded hormone pellets and creams are a different category: not FDA-approved, not batch-tested the same way, and dosing is harder to control. Some women do well on them. But if a clinic implies compounded is automatically safer or more natural than the approved version, that is marketing rather than medicine.
How we do it
Your First Appointment
- The historySymptoms, cycle, sleep, mood, and your personal and family history — particularly breast cancer, clots and cardiovascular disease. This is the part that decides whether and what.
- BloodworkThyroid, iron, vitamin D and metabolic markers, because those mimic menopause symptoms almost exactly and are missed constantly.
- The planUsually transdermal estrogen plus progesterone if you have a uterus, at the lowest dose that actually controls symptoms. Vaginal estrogen where it applies.
- Review at 8–12 weeksSymptoms take a few weeks to shift. We adjust rather than expecting the first prescription to be right.
- Then annuallyOngoing review, because this is a relationship rather than a one-off prescription.
Before you book
Questions We Get Asked Most
Did the FDA remove the warning on hormone replacement therapy?
Yes. In November 2025, following a scientific review, an expert panel and a public comment period, the FDA removed the boxed warnings about cardiovascular disease, breast cancer and probable dementia from systemic menopause hormone therapy products. A boxed warning about endometrial cancer remains on estrogen-alone products, which is why women with a uterus are prescribed progesterone alongside estrogen.
Does hormone therapy cause breast cancer?
The boxed warning stating that was removed by the FDA in November 2025 after a full review of the evidence. That does not mean risk is zero for every woman in every circumstance — it means the blanket warning was not supported. Your own history, particularly a personal or family history of breast cancer, is assessed individually before anything is prescribed.
Am I too young for hormone therapy?
Probably not. Perimenopause commonly begins in the forties and can start in the late thirties, and symptoms often arrive years before periods stop. The FDA's guidance points toward starting within ten years of menopause or before 60 for systemic therapy, which means earlier rather than later is where the evidence is strongest.
Is a patch better than a tablet?
For most women, yes, as a starting point. A patch or gel is absorbed through the skin and bypasses the liver, which carries a lower clot risk than oral estrogen. Tablets remain a reasonable choice for women who prefer them and have no specific risk factors.
Are bioidentical hormones safer than regular HRT?
Many FDA-approved products are already body-identical, including estradiol patches and micronised progesterone. Custom-compounded pellets and creams are not FDA-approved and not batch-tested the same way, so dosing is harder to control. A clinic implying compounded is automatically safer is marketing rather than medicine.
Can hormone therapy help recurrent UTIs?
Vaginal estrogen is well established for recurrent urinary tract infections after menopause. It acts locally with minimal systemic absorption, and it is frequently overlooked in women who have been given repeated courses of antibiotics instead.
How long before I feel different?
Hot flushes and sleep often improve within a few weeks. Mood, energy and brain fog usually take longer. We review at eight to twelve weeks and adjust — the first prescription is a starting point, not a verdict.
Will hormone therapy help me lose weight?
Not directly, but perimenopause changes where the body stores fat and how well it holds muscle, so treating the hormonal picture often makes weight easier to manage. Many patients here combine hormone therapy with a medical weight loss plan rather than choosing between them.
Ready when you are
Start Today
Hormone therapy starts with a proper history and bloodwork, because thyroid, iron and vitamin D mimic these symptoms almost exactly. Payment collects when you book, your consent and intake go out automatically, and your labs live in one record.